Early access to Nytheria is now open. Join the list
BG EN
Early access
Corporate profile

Innovation Creativity Opportunities Ltd

The legal and administrative entity supporting the KoleQuant brand.

CompanyInnovation Creativity Opportunities LtdUIC 208316618 · D‑U‑N‑S 665995427 · Sofia
KoleQuantCommercial brandNytheria · flagship longevity service
Innovation Creativity Opportunities LtdLegal and administrative frameworkUIC 208316618 · D‑U‑N‑S 665995427
Portfolio structure

One company. A focused portfolio.

Innovation Creativity Opportunities Ltd develops products through clear market-facing identities, each with a defined purpose and audience.

01

The company

Corporate development, contracts, intellectual property, partnerships and platform operations.

02

KoleQuant

The precision-health and applied-biosciences brand connecting biology, data and intelligent decision support.

03

Nytheria

The first flagship service: personalised precision longevity for an international audience.

Company credentials

Registered in Bulgaria. Ready to work internationally.

Core corporate information for partners, platforms and institutional relationships.

Legal nameInnovation Creativity Opportunities Ltd
Bulgarian name„Иновейшън Креативити Опъртюнитис“ ООД
UIC208316618
VATBG208316618
D‑U‑N‑S665995427
Legal formLimited liability company
Registered office and address4 81st Street, Simeonovo, Vitosha District, Sofia, Bulgaria
Product direction

Precision health today. Applied biosciences next.

Nytheria is the first flagship service. The wider portfolio will focus on digital products for exploring, interpreting and using biological data.

01

Precision health

Biomarkers, genomics, biological age and multidisciplinary interpretation.

02

Digital biosciences

Bioinformatics, visualisation and structured biological-data products.

03

Scientific tools

Software that helps users work with scientific information more effectively.

Partnerships

Build useful products from biological data.

KoleQuant works with laboratories, clinicians, researchers and technology partners that share a practical, evidence-led approach.